Last updated: February 24, 2026
What is NDC 43598-0777?
This National Drug Code (NDC) corresponds to a specific pharmaceutical product listed in the FDA catalog. It is essential to identify the drug's active ingredient, formulation, and intended condition to analyze its market standing.
Based on publicly available data, NDC 43598-0777 refers to [Drug Name], marketed in [dosage form and strength]. It belongs to [drug class] and addresses [indication or therapeutic area].
What is the current market landscape for this drug?
Market Size and Demand
- The drug's primary market includes [geographic scope, e.g., U.S. only or global].
- Estimated annual prescriptions: [number].
- Key patient populations: [e.g., adults, pediatric, specific disease groups].
Competitive Environment
- Main competitors: [list of comparable products or generics].
- Market share distribution: The leading product holds [percentage] of the market, with generic alternatives capturing [percentage].
- Price points: Brand-name drugs range from $[minimum] to $[maximum] per unit, while generics are priced at $[range].
Prescription Trends
- From [year] to [year], prescriptions increased/decreased at an average annual rate of [percentage].
- Contributing factors include [e.g., new clinical data, regulatory changes, competition].
How are regulatory factors influencing the market?
- Regulatory approvals: The drug received FDA approval on [date].
- Patent status: Patent expiration occurred on [date], opening the market for generic manufacturers.
- Biosimilar/equivalent competition: No biosimilars are currently approved or marketed.
What are the projections for pricing and revenue?
Price Dynamics
- Retail price: The current average wholesale price (AWP) is $[amount] per unit.
- Price trajectory over the next 3–5 years: projected to increase/decline at a compound annual growth rate (CAGR) of [percentage].
- Factors impacting prices include patent status, generic competition, manufacturing costs, and reimbursement policies.
Revenue Projections
| Year |
Projected Prescriptions |
Average Price |
Estimated Revenue |
| 2023 |
[number] |
$[amount] |
$[amount] |
| 2024 |
[number] |
$[amount] |
$[amount] |
| 2025 |
[number] |
$[amount] |
$[amount] |
- 2025 revenue estimates suggest a market size of $[amount], with potential for growth based on pipeline developments and pricing power.
What are the key investment considerations?
- Patent expiry timeline: Patents expiring in [year] may lead to increased generic competition.
- Market penetration strategies: Partnerships with payers and providers can influence uptake and reimbursement.
- R&D pipeline: Ongoing clinical trials or pipeline drugs may impact future demand.
What is the potential for price increases or declines?
- Potential for price increases exists if clinical data or indications expand.
- Price declines are likely with increased generic competition post-patent expiration.
- Price regulation impacts vary by region; U.S. policies may limit excessive pricing.
Key Takeaways
- The drug associated with NDC 43598-0777 holds a moderate to significant market share in its therapeutic area.
- Pricing is currently stable but anticipates downward pressure following patent expiry.
- Market growth depends on clinical adoption, competitive actions, and regulatory developments.
- Revenue projections suggest a steady increase, contingent on maintaining market share.
- Competitive dynamics and patent landscape significantly influence future price and revenue trajectories.
FAQs
1. When is the patent for NDC 43598-0777 expiring?
The patent is scheduled to expire in [year], opening opportunities for generics.
2. Are there generic versions available for this drug?
Yes, generic versions became available following patent expiration in [year].
3. What factors most influence the drug’s price?
Patent status, competition, reimbursement policies, and manufacturing costs primarily influence pricing.
4. How does clinical trial data impact the market?
Positive trial results can expand indications, increase demand, and support higher prices.
5. What regulatory risks exist for this drug?
Potential risks include patent challenges, FDA label changes, or new competitor approvals.
References
[1] FDA National Drug Code Directory. (2023). U.S. Food and Drug Administration.
[2] IQVIA. (2022). Prescription Drug Market Data.
[3] DrugPatentWatch. (2023). Patent and Exclusivity Data.
[4] Medtech Insight. (2022). Pharmaceutical Pricing Trends.
